Gravity Blood Sets with 200µm Filter
B. BRAUN MEDICAL INC. · Decision date Oct 22, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-10-22 for K260261, a traditional 510(k) submitted by B.Braun Medical, Inc. of Bethlehem, Pennsylvania, and received on 01/28/2026. The device is listed as Gravity Blood Sets with 200µm Filter, classified under regulation 880.5440 as an intravascular administration set with product code FPA in the General Hospital specialty. SESE denotes clearance to market, not premarket approval of the device.
The record identifies the applicant contact as Stacia Preston and notes the review was not conducted by a third party, was not a combination product, and carried no authorized predetermined change control plan. The available material does not include the summary's substantive content, so the specific component changes, predicate device, and any performance data supporting equivalence remain unknown. No clinical, safety, or labeling conclusions are drawn here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General Hospital
- Decision date
- Oct 22, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260261
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- B. BRAUN MEDICAL INC.
- Product code
- FPA
- Decision code
- SESE
- Decision date
- Oct 22, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Set, Administration, Intravascular.
- Applicant
- B. BRAUN MEDICAL INC.
- Product code
- FPA
- FDA device class
- 2
FDA decision timeline
K260261 received
Application receipt date recorded by FDA.
K260261 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code FPA
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Ecomed Solutions, LLC | 510(k) clearance | Sep 11, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
B. BRAUN MEDICAL INC.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Bethlehem, PA
Sources and methodology
- Original FDA record: K260261
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records